Results 11 to 20 of about 5,569 (193)
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β<sub>2</sub>-Agonists Used for Asthma and COPD. [PDF]
ABSTRACT β‐agonists have been used in asthma for 120 years. There are two recent changes: ultra‐long‐acting agonists for COPD and new asthma guidelines recommending formoterol/ICS inhalers phasing out short‐acting salbutamol inhalers. Few studies directly compare the molecular pharmacological properties of short (salbutamol, terbutaline, fenoterol ...
Proudman RGW, Baker JG.
europepmc +2 more sources
Anticholinergic therapy for acute asthma in children. [PDF]
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta(2)-agonists) are one of the several medications available for the treatment of acute asthma in ...
Beakes +49 more
core +2 more sources
In vitro transdermal permeation of fenoterol hydrobromide
The aim of this study was to determine if transdermal penetration of fenoterol, a β-agonist drug, could be enhanced and controlled by formulation modification and formulation of transdermal patches. Pre-formulation studies were performed to determine the
Ahmed H. Elshafeey +3 more
doaj +1 more source
Management of Painful Post-Traumatic Trigeminal Neuropathy With Topical Anesthesia Combined With a Psychological Approach: A Case Report. [PDF]
ABSTRACT This case report presents a patient with painful post‐traumatic trigeminal neuropathy (PPTTN) following a tooth extraction, requiring re‐surgical intervention. The patient had several critical systemic conditions, necessitating the minimal use of systemic medications. This case responded favorably to the use of topical anesthesia combined with
Limrachtamorn T, Limrachtamorn T.
europepmc +2 more sources
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]
An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Altman +18 more
core +1 more source
Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Altman +17 more
core +1 more source
The purpose of the article is to determine the place of the combined bronchodilator fenoterol + ipratropium bromide in the treatment of exacerbations of bronchial asthma, COPD and recommendations on various delivery methods.
О. A. Tsvetkova, O. O. Voronkova
doaj +1 more source
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review) [PDF]
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Cates, CJ, Jaeschke, R, Lasserson, TJ
core +1 more source
Avaliaram-se, por meio de exame clínico, hemogasométrico e eletrocardiográfico, os efeitos do salbutamol e do fenoterol, administrados por via inalatória em cães.
R.M. Viel +6 more
doaj +1 more source
The purpose of the study was to compare the efficacy of regular prolonged inhalation therapy with tiotropium bromide delivered via the Respimat inhaler and short-acting bronchodilator (SAB) therapy with ipratropium bromide/fenoterol in the perioperative ...
S. Yu. Dobner +8 more
doaj +1 more source

